Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Grassmann F"" wg kryterium: Wszystkie pola


Tytuł:
The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice.
Autorzy:
Pfaller AM; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Kaplan L; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Carido M; Helmholtz Pioneer Campus, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Grassmann F; Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany.; Institute for Clinical Research and Systems Medicine, Health and Medical University, Potsdam, Germany.
Díaz-Lezama N; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.; Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Ghaseminejad F; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Wunderlich KA; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.; Institute for Molecular Medicine, Health and Medical University, Potsdam, Germany.
Glänzer S; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Bludau O; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Pannicke T; Paul Flechsig Institute for Brain Research, University of Leipzig, Leipzig, Germany.
Weber BHF; Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany.; Institute of Human Genetics, University Regensburg, Regensburg, Germany.
Koch SF; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.; Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Bonev B; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.; Helmholtz Pioneer Campus, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Hauck SM; Metabolomics and Proteomics Core, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Grosche A; Department of Physiological Genomics, Biomedical Center-BMC, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2024 Jan 25; Vol. 21 (1), pp. 33. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*/metabolism
Diabetic Retinopathy*/genetics
Diabetic Retinopathy*/metabolism
Animals ; Mice ; Ependymoglial Cells/metabolism ; Neuroglia/metabolism ; Receptors, Glucocorticoid/genetics ; Receptors, Glucocorticoid/metabolism ; Retina/metabolism
Czasopismo naukowe
Tytuł:
Correction: Bipolar haemostatic forceps versus standard therapy by haemoclip + / - epinephrine injection as initial endoscopic treatment in active non-variceal upper GI bleeding: study protocol for a prospective, randomized multicentre trial (BeBop-Trial).
Autorzy:
Schmitz D; Department of Gastroenterology and Infectiology, Helios Kliniken Schwerin, University Campus of Medical School Hamburg, Wismarsche Str.393-397, Schwerin, 19055, Germany. .
Thielemann L; Department of Gastroenterology and Infectiology, Helios Kliniken Schwerin, University Campus of Medical School Hamburg, Wismarsche Str.393-397, Schwerin, 19055, Germany.
Grassmann F; Department of Medical Statistics and Epidemiology, Medical School Hamburg, Am Kaiserkai 1, Hamburg, 20457, Germany.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Nov 10; Vol. 24 (1), pp. 718. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Published Erratum
Tytuł:
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Autorzy:
Morra A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Schreurs MAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Anton-Culver H; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California, USA.
Augustinsson A; Oncology, Clinical Sciences in Lund, Lund University, Lund, Sweden.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Tübingen, Germany.
Broeks A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Buys SS; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
Cessna MH; Intermountain Healthcare, Salt Lake City, Utah, USA.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, New York, USA.
Colonna SV; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Cox A; Department of Oncology and Metabolism, Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield, Sheffield, UK.
Cross SS; Department of Neuroscience, Academic Unit of Pathology, University of Sheffield, Sheffield, UK.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Dunning AM; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Dwek M; School of Life Sciences, University of Westminster, London, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Eccles DM; Faculty of Medicine, University of Southampton, Southampton, UK.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Fehm TN; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Figueroa JD; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Gago-Dominguez M; Cancer Genetics and Epidemiology Group, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
García-Closas M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
García-Sáenz JA; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Genkinger J; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.; Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Health and Medical University, Potsdam, Germany.
Gündert M; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Harrington PA; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Hartikainen JM; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Howell A; Division of Cancer Sciences, University of Manchester, Manchester, UK.
Jakubowska A; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
Janni W; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Jernström H; Oncology, Clinical Sciences in Lund, Lund University, Lund, Sweden.
John EM; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Kristensen VN; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Kurian AW; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Lux MP; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Nevelsteen I; Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Neven P; Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Newman WG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Obi N; Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Olshan AF; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Park-Simon TW; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Patel AV; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA.
Peterlongo P; IFOM ETS - The AIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy.
Phillips KA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', MASA, Skopje, Republic of North Macedonia.
Polley EC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Presneau N; School of Life Sciences, University of Westminster, London, UK.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
Rack B; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Radice P; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 'Predictive Medicine: Molecular Bases of Genetic Risk', Milan, Italy.
Rashid MU; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.
Rhenius V; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Robson M; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Romero A; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Saloustros E; Department of Oncology, University Hospital of Larissa, Larissa, Greece.
Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London, UK.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schuetze S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Scott C; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Shah M; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Smichkoska S; Medical Faculty, University Clinic of Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Tapper WJ; Faculty of Medicine, University of Southampton, Southampton, UK.
Teras LR; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA.
Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Tomczyk K; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Tomlinson I; Cancer Research Centre, The University of Edinburgh, Edinburgh, UK.
Troester MA; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Vachon CM; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
van Veen EM; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wendt C; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Wildiers H; Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
Ziogas A; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California, USA.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Adank MA; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
NBCS Collaborators; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Research, Vestre Viken Hospital, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Division of Surgery, Cancer and Transplantation Medicine, Department of Oncology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Oslo Breast Cancer Research Consortium, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.; Core Facility for Biobanking, The Arctic University of Norway, Tromsø, Norway.
ABCTB Investigators; Australian Breast Cancer Tissue Bank, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
kConFab Investigators; Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 16142-16162. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Breast Neoplasms*/genetics
Breast Neoplasms*/radiotherapy
Female ; Humans ; Checkpoint Kinase 2/genetics ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Heterozygote ; Proportional Hazards Models
Czasopismo naukowe
Tytuł:
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
Autorzy:
Figlioli G; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Billaud A; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Kvist A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, 22185 Lund, Sweden.
Adank MA; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Family Cancer Clinic, 1066 CX Amsterdam, The Netherlands.
Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.
Auvinen P; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Oncology, University of Eastern Finland, 70210 Kuopio, Finland.; Department of Oncology, Cancer Center, Kuopio University Hospital, 70210 Kuopio, Finland.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Bermisheva M; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia.
Bogdanova NV; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Bojesen SE; Copenhagen General Population Study, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.; Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany.
Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Campbell A; Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh EH4 2XU, UK.; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH16 4UX, UK.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, 36312 Vigo, Spain.
Cessna MH; Intermountain Health, Salt Lake City, UT 84111, USA.
Nbcs Collaborators; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, 0379 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.; Department of Research, Vestre Viken Hospital, 3019 Drammen, Norway.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.; Section for Breast- and Endocrine Surgery, Department of Cancer, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Ullevål, 0450 Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.; Department of Pathology, Akershus University Hospital, 1478 Lørenskog, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Department of Oncology, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Radiumhospitalet, 0379 Oslo, Norway.; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, 0379 Oslo, Norway.; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway.; Oslo Breast Cancer Research Consortium, Oslo University Hospital, 0379 Oslo, Norway.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
Devilee P; Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Dörk T; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Flyger H; Department of Breast Surgery, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
Gago-Dominguez M; Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS) Foundation, IDIS Cancer Genetics and Epidemiology Group, Genomic Medicine Group, Complejo Hospitalario Universitario de Santiago, SERGAS, 15706 Santiago de Compostela, Spain.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON M5G 1X5, Canada.; Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada.
Gómez Garcia EB; Department of Clinical Genetics, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
González-Neira A; Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Medicine, Institute for Clinical Research and Systems Medicine, Health and Medical University, 14467 Potsdam, Germany.
Guénel P; CESP U1018, Inserm 'Exposome, Heredity, Cancer and Health' Team, UVSQ, University Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.
Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, 69120 Heidelberg, Germany.
Hillemanns P; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tübingen, 72074 Tübingen, Germany.
Howell A; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
kConFab Investigators; Research Department, Peter MacCallum Cancer Center, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3000, Australia.
Jakubowska A; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Khusnutdinova EK; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia.; Department of Genetics and Fundamental Medicine, Ufa University of Science and Technology, 450076 Ufa, Russia.
Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0379 Oslo, Norway.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Loizidou MA; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210 Kuopio, Finland.; Kuopio University Hospital, Biobank of Eastern Finland, 70210 Kuopio, Finland.
Maurer T; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, 711 10 Heraklion, Greece.
Newman WG; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Obi N; University Medical Center Hamburg-Eppendorf, Institute for Medical Biometry and Epidemiology, 20246 Hamburg, Germany.
Panayiotidis MI; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
Radice P; Unit of 'Predictive Medicine: Molecular Bases of Genetic Risk', Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy.
Rashid MU; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, 69120 Heidelberg, Germany.; Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore 54000, Pakistan.
Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Ruebner M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Saloustros E; Department of Oncology, University Hospital of Larissa, 411 10 Larissa, Greece.
Sawyer EJ; King's College London, School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, London SE1 9RT, UK.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC 3000, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.
Tomlinson I; Cancer Research Centre, The University of Edinburgh, Edinburgh EH4 2XU, UK.
Truong T; CESP U1018, Inserm 'Exposome, Heredity, Cancer and Health' Team, UVSQ, University Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.
van Veen EM; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Wendt C; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, 118 83 Stockholm, Sweden.
Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.; Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA 90069, USA.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Evans DG; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Milne RL; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia.
Peterlongo P; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jun 23; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Bipolar haemostatic forceps versus standard therapy by haemoclip + / - epinephrine injection as initial endoscopic treatment in active non-variceal upper GI bleeding: study protocol for a prospective, randomized multicentre trial (BeBop-Trial).
Autorzy:
Schmitz D; Department of Gastroenterology and Infectiology, Helios Kliniken Schwerin, University Campus of Medical School Hamburg, Wismarsche Str.393-397, Schwerin, 19055, Germany. .
Thielemann L; Department of Gastroenterology and Infectiology, Helios Kliniken Schwerin, University Campus of Medical School Hamburg, Wismarsche Str.393-397, Schwerin, 19055, Germany.
Grassmann F; Department of Medical Statistics and Epidemiology, Medical School Hamburg, Am Kaiserkai 1, Hamburg, 20457, Germany.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Jun 15; Vol. 24 (1), pp. 407. Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Epinephrine*/adverse effects
Hemostatics*
Humans ; Prospective Studies ; Gastrointestinal Hemorrhage/therapy ; Surgical Instruments ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
Percutaneous transhepatic or endoscopic ultrasound-guided biliary drainage in malignant distal bile duct obstruction using a self-expanding metal stent: Study protocol for a prospective European multicenter trial (PUMa trial).
Autorzy:
Schmitz D; Department of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus und St. Hedwig-Klinik, Lehrkrankenhaus der Universität Heidelberg, Mannheim, Germany.; Department of Gastroenterology and Infectiology, Helios Kliniken Schwerin, Schwerin, Germany.
Valiente CT; Department of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus und St. Hedwig-Klinik, Lehrkrankenhaus der Universität Heidelberg, Mannheim, Germany.
Dollhopf M; Department of Gastroenterology and Hepatology, München Klinik Neuperlach, München, Germany.
Perez-Miranda M; Department of Gastrointestinal Endoscopy, Hospital Universitario Río Hortega, Valladolid, Spain.
Küllmer A; Department of Medicine II: Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Universitätsklinikum Freiburg, Freiburg, Germany.
Gornals J; Department of Digestive Diseases, Hospital Universitari de Bellvitge, Barcelona, Spain.
Vila J; Endoscopy Unit, Complejo Hospitalario de Navarra, Pamplona, Spain.
Weigt J; Department of Gastroenterology, Hepatology and Infectiology, Universitätsklinikum Magdeburg, Magdeburg, Germany.
Voigtländer T; Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany.
Redondo-Cerezo E; Department of Gastrointestinal Endoscopy, Hospital universitario Virgen de las Nieves, Granada, Spain.
von Hahn T; Department of Gastroenterology, Hepatology, and Interventional Endoscopy, Asklepios Klinik Barmbek, Hamburg, Germany.
Albert J; Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
Vom Dahl S; Department of Gastroenterology, Hepatology and Infectiology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Beyna T; Department of Internal Medicine, Gastroenterology and Interventional Endoscopy Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany.
Hartmann D; Department of General Internal Medicine, Diabetology, Gastroenterology and Oncology, Katholisches Klinikum Mainz, Mainz, Germany.
Franck F; Department of Gastroenterology and Hepatology, München Klinik Neuperlach, München, Germany.
García-Alonso FJ; Department of Gastrointestinal Endoscopy, Hospital Universitario Río Hortega, Valladolid, Spain.
Schmidt A; Department of Medicine II: Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Universitätsklinikum Freiburg, Freiburg, Germany.
Garcia-Sumalla A; Department of Digestive Diseases, Hospital Universitari de Bellvitge, Barcelona, Spain.
Arrubla A; Endoscopy Unit, Complejo Hospitalario de Navarra, Pamplona, Spain.
Joerdens M; Department of Gastroenterology, Hepatology and Infectiology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Kleemann T; Department of Gastroenterology and Rheumatology, Carl-Thiem-Klinikum Cottbus, Cottbus, Germany.
Tomo JRA; Department of Digestive Diseases, Hospital General Universitario de Alicante, Alicante, Spain.
Grassmann F; Institute for Medical Statistics and Epidemiology, Medical School Hamburg, Hamburg, Germany.
Rudi J; Department of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus und St. Hedwig-Klinik, Lehrkrankenhaus der Universität Heidelberg, Mannheim, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Oct 27; Vol. 17 (10), pp. e0275029. Date of Electronic Publication: 2022 Oct 27 (Print Publication: 2022).
Typ publikacji:
Controlled Clinical Trial; Equivalence Trial; Journal Article
MeSH Terms:
Cholestasis*/diagnostic imaging
Cholestasis*/surgery
Humans ; Cholangiopancreatography, Endoscopic Retrograde/adverse effects ; Drainage/adverse effects ; Drainage/methods ; Endosonography/methods ; Multicenter Studies as Topic ; Prospective Studies ; Retrospective Studies ; Stents/adverse effects ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł:
A systems genomics approach to uncover the molecular properties of cancer genes.
Autorzy:
Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, 171 65, Stockholm, Sweden. felix.grassmann@ki.se.
Pawitan Y; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, 171 65, Stockholm, Sweden.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, 171 65, Stockholm, Sweden.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Oct 27; Vol. 10 (1), pp. 18392. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Systems Biology*
Genomics/*methods
Neoplasms/*genetics
Algorithms ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Linkage Disequilibrium ; Mutation ; Proof of Concept Study
Czasopismo naukowe
Tytuł:
Pleiotropic Locus 15q24.1 Reveals a Gender-Specific Association with Neovascular but Not Atrophic Age-Related Macular Degeneration (AMD).
Autorzy:
Kiel C; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
Strunz T; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
International Amd Genomics Consortium Project Manager Susan Blanton Iamdgc; John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA.
Grassmann F; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.; Institute of Medical Sciences, University of Aberdeen, King's College, Aberdeen, AB24 3FX, UK.
Weber BHF; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.; Institute of Clinical Human Genetics, University Hospital Regensburg, 93053 Regensburg, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2020 Oct 08; Vol. 9 (10). Date of Electronic Publication: 2020 Oct 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Macular Degeneration/*genetics
MicroRNAs/*genetics
Choroidal Neovascularization/genetics ; Choroidal Neovascularization/metabolism ; Chromosomes, Human, Pair 15/genetics ; Databases, Genetic ; Female ; Genetic Loci/genetics ; Genetic Pleiotropy/genetics ; Genetic Predisposition to Disease/genetics ; Genome-Wide Association Study/methods ; Humans ; Male ; MicroRNAs/metabolism ; Polymorphism, Single Nucleotide/genetics ; Sex Factors
Czasopismo naukowe
Tytuł:
A mega-analysis of expression quantitative trait loci in retinal tissue.
Autorzy:
Strunz T; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
Kiel C; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
Grassmann F; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.; Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Ratnapriya R; Neurobiology-Neurodegeneration & Repair Laboratory, National Eye Institute, Bethesda, United States of America.
Kwicklis M; Neurobiology-Neurodegeneration & Repair Laboratory, National Eye Institute, Bethesda, United States of America.
Karlstetter M; Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Fauser S; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Arend N; Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.
Swaroop A; Neurobiology-Neurodegeneration & Repair Laboratory, National Eye Institute, Bethesda, United States of America.
Langmann T; Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Wolf A; Department of Ophthalmology, University of Ulm, Ulm, Germany.
Weber BHF; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.; Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2020 Sep 01; Vol. 16 (9), pp. e1008934. Date of Electronic Publication: 2020 Sep 01 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Retina/*metabolism
Retina/*physiology
Retinal Diseases/*genetics
Autopsy ; Gene Expression/genetics ; Gene Expression Profiling/methods ; Gene Expression Regulation/genetics ; Genetic Predisposition to Disease/genetics ; Genetic Variation/genetics ; Genome-Wide Association Study/methods ; Genomics/methods ; Genotype ; Healthy Volunteers ; Humans ; Phenotype ; Polymorphism, Single Nucleotide/genetics ; Quantitative Trait Loci/genetics
Czasopismo naukowe
Tytuł:
Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease.
Autorzy:
Winkler TW; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany. .
Grassmann F; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK.
Brandl C; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.; Department of Ophthalmology, University Hospital Regensburg, Regensburg, Germany.
Kiel C; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
Günther F; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.; Statistical Consulting Unit StaBLab, Department of Statistics, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Strunz T; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
Weidner L; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Zimmermann ME; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Korb CA; Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Poplawski A; Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Schuster AK; Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Müller-Nurasyid M; Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Department of Internal Medicine I (Cardiology), Hospital of the Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.; Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, Munich, Germany.
Peters A; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.
Rauscher FG; Leipzig Research Centre for Civilization Diseases (LIFE), Leipzig University, Leipzig, Germany.; Institute for Medical Informatics, Statistics, and Epidemiology (IMISE), Leipzig University, Leipzig, Germany.
Elze T; Leipzig Research Centre for Civilization Diseases (LIFE), Leipzig University, Leipzig, Germany.; Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA.
Horn K; Leipzig Research Centre for Civilization Diseases (LIFE), Leipzig University, Leipzig, Germany.; Institute for Medical Informatics, Statistics, and Epidemiology (IMISE), Leipzig University, Leipzig, Germany.
Scholz M; Leipzig Research Centre for Civilization Diseases (LIFE), Leipzig University, Leipzig, Germany.; Institute for Medical Informatics, Statistics, and Epidemiology (IMISE), Leipzig University, Leipzig, Germany.
Cañadas-Garre M; Centre for Public Health, Queen's University of Belfast, Belfast, UK.
McKnight AJ; Centre for Public Health, Queen's University of Belfast, Belfast, UK.
Quinn N; Centre for Public Health, Queen's University of Belfast, Belfast, UK.
Hogg RE; Centre for Public Health, Queen's University of Belfast, Belfast, UK.
Küchenhoff H; Statistical Consulting Unit StaBLab, Department of Statistics, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Heid IM; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Stark KJ; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Weber BHF; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.; Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2020 Aug 26; Vol. 13 (1), pp. 120. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Loci*
Genetic Markers*
Genetic Predisposition to Disease*
Genome-Wide Association Study*
Polymorphism, Single Nucleotide*
Macular Degeneration/*genetics
Macular Degeneration/*pathology
Case-Control Studies ; Humans
Czasopismo naukowe
Tytuł:
Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors.
Autorzy:
Yang H; Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Xuefu North Road 1, University Town, Fuzhou, 350122, China. .; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden. .
Holowko N; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden.
Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden.; Department of Oncology, South General Hospital, SE-11883, Stockholm, Sweden.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2020 Aug 25; Vol. 18 (1), pp. 225. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*etiology
Genetic Pleiotropy/*genetics
Genetic Predisposition to Disease/*genetics
Hyperthyroidism/*complications
Mammography/*methods
Adult ; Breast Neoplasms/genetics ; Cohort Studies ; Female ; Humans ; Hyperthyroidism/pathology ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł:
A Circulating MicroRNA Profile in a Laser-Induced Mouse Model of Choroidal Neovascularization.
Autorzy:
Kiel C; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
Berber P; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
Karlstetter M; Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, 50931 Cologne, Germany.
Aslanidis A; Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, 50931 Cologne, Germany.
Strunz T; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
Langmann T; Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, 50931 Cologne, Germany.
Grassmann F; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, 171 77 Stockholm, Sweden.
Weber BHF; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.; Institute of Clinical Human Genetics, University Clinics Regensburg, 93053 Regensburg, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Apr 13; Vol. 21 (8). Date of Electronic Publication: 2020 Apr 13.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Choroidal Neovascularization/*blood
Choroidal Neovascularization/*etiology
Circulating MicroRNA/*genetics
Lasers/*adverse effects
Animals ; Cells, Cultured ; Choroidal Neovascularization/metabolism ; Choroidal Neovascularization/pathology ; Disease Models, Animal ; Disease Susceptibility ; Endothelial Cells/metabolism ; Female ; Gene Expression Profiling ; Gene Expression Regulation ; High-Throughput Nucleotide Sequencing ; Mice ; MicroRNAs/genetics ; Microglia/metabolism ; Retina/metabolism ; Retinal Pigment Epithelium/metabolism ; Transcriptome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies